Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Clinical trial NCT07179380 · RECRUITING
Trial details
- NCT number
- NCT07179380
- Sponsor
- Insmed Incorporated
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-07
- Primary completion
- 2028-12-30
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.